- Home
- NMRA vs BIOX Comparison
NMRA vs BIOX Comparison
Compare NMRA & BIOX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NMRA
- BIOX
- Stock Information
- Founded
- NMRA 2019
- BIOX 2001
- Country
- NMRA United States
- BIOX Argentina
- Employees
- NMRA N/A
- BIOX N/A
- Industry
- NMRA
- BIOX Agricultural Chemicals
- Sector
- NMRA
- BIOX Industrials
- Exchange
- NMRA Nasdaq
- BIOX Nasdaq
- Market Cap
- NMRA 121.0M
- BIOX 302.3M
- IPO Year
- NMRA 2023
- BIOX N/A
- Fundamental
- Price
- NMRA $0.80
- BIOX $4.59
- Analyst Decision
- NMRA Buy
- BIOX Strong Buy
- Analyst Count
- NMRA 8
- BIOX 4
- Target Price
- NMRA $9.29
- BIOX $8.63
- AVG Volume (30 Days)
- NMRA 1.4M
- BIOX 125.7K
- Earning Date
- NMRA 08-05-2025
- BIOX 05-21-2025
- Dividend Yield
- NMRA N/A
- BIOX N/A
- EPS Growth
- NMRA N/A
- BIOX N/A
- EPS
- NMRA N/A
- BIOX N/A
- Revenue
- NMRA N/A
- BIOX $383,289,394.00
- Revenue This Year
- NMRA N/A
- BIOX N/A
- Revenue Next Year
- NMRA N/A
- BIOX $7.30
- P/E Ratio
- NMRA N/A
- BIOX N/A
- Revenue Growth
- NMRA N/A
- BIOX N/A
- 52 Week Low
- NMRA $0.61
- BIOX $3.51
- 52 Week High
- NMRA $17.19
- BIOX $11.78
- Technical
- Relative Strength Index (RSI)
- NMRA 44.07
- BIOX 48.53
- Support Level
- NMRA $0.72
- BIOX $4.22
- Resistance Level
- NMRA $0.85
- BIOX $4.80
- Average True Range (ATR)
- NMRA 0.07
- BIOX 0.29
- MACD
- NMRA -0.02
- BIOX -0.03
- Stochastic Oscillator
- NMRA 8.08
- BIOX 39.78
About NMRA Neumora Therapeutics Inc.
Neumora Therapeutics Inc is a clinical-stage biopharmaceutical company founded to confront the brain disease crisis by taking a fundamentally different approach to the way treatments for brain diseases are developed. It has scaled its therapeutic pipeline, which currently consists of seven clinical and preclinical neuroscience programs that target novel mechanisms of action for a broad range of underserved neuropsychiatric disorders and neurodegenerative diseases. Its pipeline includes NMRA-140, NMRA-511, NMRA-266, NMRA-M4R, NMRA-NMDA, NMRA-CK1O, NMRA-NLRP3, and NMRA-GCASE. The group's pipeline is building programs for underserved neuropsychiatric disorders and neurodegenerative diseases.
About BIOX Bioceres Crop Solutions Corp.
Bioceres Crop Solutions Corp is a fully integrated provider of crop productivity solutions, including seeds, seed traits, seed treatments, biologicals, high-value adjuvants, and fertilizers. The company has developed a multi-discipline and multi-product platform capable of providing solutions throughout the entire crop cycle, from pre-planting to transportation and storage. Some of the products offered by the company include fertilizers, inoculants, adjuvants, crop protection solutions, and seeds among others. Its operating segments are crop protection, which derives key revenue, seed and integrated products, and crop nutrition. Geographically, the majority of the company's revenue is generated from Argentina and the rest from Brazil, North America, Latin America, and other regions.